ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant

Journal of Heart and Lung Transplantation

Volumn 23, Issue 10, 2004, Pages 1163-1169

  Hariya, Akifusa ^a   Takazawa, Kenji ^a   Yamamoto, Taira ^a   Amano, Atsushi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHOXYMETHOXY N HYDROXY 2 METHYL 4 (4 PHENOXYBENZAMIDO)PENTANAMIDE; GELATINASE A; MATRIX METALLOPROTEINASE INHIBITOR; N HYDROXY 5 ETHOXYMETHYLOXY 2 METHYL 4 (4 PHENOXYBENZOYL)AMINOPENTANAMIDE; TACROLIMUS; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFICACY; GRAFT FAILURE; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUNICA MEDIA; VASCULAR DISEASE;

ANIMALS; CORONARY DISEASE; CORONARY VESSELS; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; PHENYL ETHERS; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED F344; RATS, INBRED STRAINS; TACROLIMUS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSPLANTATION, HOMOLOGOUS;

EID: 5144226917     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.08.022     Document Type: Article

References (25)

1. Hertz M.I., Taylor D.O., Trulock E.P., et al. The Registry of the International Society for Heart and Lung Transplantation nineteeth official report - 2002. J Heart Lung Transplant. 21:2002;950-970
2. Billingham M.E. Histopathology of graft vascular disease. J Heart Lung Transplant. 11:1992;S38-S44
3. Sasaguri S., Tsukada T., Hosoda Y. Immunocytochemical investigations of vessel allograft arteriosclerosis using smooth muscle cell-and macrophage-specific monoclonal antibodies. Transplantation. 50:1990;898-901
4. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular desease. Circ Res. 77:1995;863-868
5. Sakalihasan N., Delvenne P., Nusgens B.V., et al. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg. 24:1996;127-133
6. Ishii T., Azuwa N. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in aortic dissection. Hum Pathol. 31:2000;640-646
7. McMillan W.D., Patterson B.K., Keen R.R., et al. In situ localization and quantification of seventy-two-killodalton type IV collagenase in aneurysmal, occlusive and normal aorta. J Vasc Surg. 22:1995;295-305
8. Aikawa M., Rabkin E., Okada Y., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma. Circulation. 97:1998;2433-2444
9. Yamada A., Uegaki A., Nakamura T., et al. ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs. Inflamm Res. 49:2000;144-146
10. Ono K., Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 57:1969;225
11. Billingham M.E., Cary N.R.B., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection Heart Rejection Study Group. J Heart Lung Transplant. 9:1990;587-593
12. Tatsuguchi A., Fukuda Y., Ishizaki M., et al. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Digestion. 60:1999;246-254
13. Nakagawa T., Kubota T., Kabuto M., et al. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg. 81:1994;69-77
14. Damoiseaux J.G., Dopp E.A., Calame W., et al. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology. 83:1994;140
15. Shiraga M., Yano S., Yamamoto A., et al. Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multi-organ metastasis by lung cancer cell lines. Cancer Res. 62:2002;5967-5973
16. Yamamoto A., Yano S., Shiraga M., et al. A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice. Int J Cancer. 103:2003;822-828
17. Andrew W.M., Peter D.B., Jeff M., et al. Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers. Br J Clin Pharmacol. 45:1998;21-26
18. Lawrence J.M., Erol K.B., Michael P.C., et al. Discovery of CGS27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J Med Chem. 40:1997;2525-2532
19. Mori T., Yamasaki S., Masui F., et al. Suppression of the development of experimently induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice. Exp Biol Med. 226:2001;429-433
20. Tsukioka K., Suzuki J., Kawauchi M., et al. Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplantated primate hearts. J Heart Lung Transplant. 19:2000;1193-1198
21. Aoyagi M., Yamamoto M., Azuma H., et al. Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation. Histochem Cell Biol. 109:1998;97-102
22. Jenkins G.M., Crow M.T., Bilato C., et al. Increased expression membrane-type matrix metalloproteinase-2 to the neointima of balloon injured rat carotid arteries. Circulation. 97:1998;82-90
23. Tsukioka K., Suzuki J., Fujimori M., et al. Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection. Cardiovasc Res. 56:2002;472-478
24. Jain S., Bicknell G.R., Nicholson M.L. Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Br J Surg. 87:2000;1563-1568
25. Shek F.W., Benyon R.C., Walker F.M., et al. Expression transforming growth factor-β by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol. 160:2002;1787-1798